Table 3: Association between variables of interest and three treatment groups.
Variable |
Lumpectomy Alone n = 4768 |
Local Therapy n = 15446 |
Systemic Therapy n = 14230 |
p-value |
|
Age at diagnosis |
Mean |
63.7 |
60.03 |
57.8 |
< 0.001 |
Median |
64 |
60 |
58 |
||
Std Dev |
13.25 |
11.77 |
10.35 |
||
Age (quartile) |
> = 23, < = 51 |
1003 (21.04) |
4083 (26.43) |
4342 (30.51) |
< 0.001 |
> 51 < = 59 |
880 (18.46) |
3456 (22.37) |
3723 (26.16) |
||
> 59, < = 68 |
1045 (21.92) |
3986 (25.81) |
3863 (27.15) |
||
> 68, < = 90 |
1840 (38.59) |
3921 (25.39) |
2302 (16.18) |
||
Race |
White |
3930 (82.42) |
12852 (83.21) |
11602 (81.53) |
0.002 |
Black |
576 (12.08) |
1804 (11.68) |
1869 (13.13) |
||
Other/Unknown |
262 (5.49) |
790 (5.11) |
759 (5.33) |
||
Carlson-Deyo Score |
0 |
4132 (86.66) |
13197 (85.44) |
12418 (87.27) |
< 0.001 |
1 |
523 (10.97) |
1901 (12.31) |
1551 (10.9) |
||
2+ |
113 (2.37) |
348 (2.25) |
261 (1.83) |
||
Facility Type |
Commun. Cancer Program/Other |
431 (9.22) |
1234 (8.2) |
1506 (10.77) |
< 0.001 |
Comp Commun Cancer Program |
2396 (51.24) |
7559 (50.21) |
7006 (50.08) |
||
Academic/Research Program |
1228 (51.24) |
4216 (28.01) |
3599 (25.73) |
||
Integrated Network Cancer Program |
621 (13.28) |
2045 (13.58) |
1878 (13.42) |
||
Primary Payor |
Not Insured/Unknown |
141 (2.96) |
392 (2.54) |
381 (2.68) |
<0.001 |
Private |
2367 (49.64) |
9087 (58.83) |
9303 (65.38) |
||
Medicaid/Other Government |
208 (4.36) |
739 (4.91) |
855 (6.01) |
||
Medicare |
2052 (43.04) |
5208 (33.72) |
3691 (25.94) |
||
Year of Diagnosis |
> = 2004, < = 2008 |
1603 (33.62) |
5078 (32.88) |
4346 (30.54) |
< 0.001 |
> 2008, < = 2010 |
1508 (31.63) |
5199 (33.66) |
4613 (32.42) |
||
> 2010, < = 2012 |
813 (17.05) |
2609 (16.89) |
2599 (18.26) |
||
> 2012, < = 2013 |
844 (17.7) |
2560 (16.57) |
2672 (18.78) |
||
Histology |
Ductal |
3696 (77.52) |
11163 (72.27) |
10499 (73.78) |
< 0.001 |
Comedocarcinoma |
593 (12.44) |
3108 (20.12) |
2429 (17.07) |
||
Papillary |
238 (4.99) |
390 (2.52) |
454 (3.19) |
||
Ductal + lobular |
241 (5.05) |
785 (5.08) |
848 (5.96) |
||
Hormonal Receptor Status |
ER/PR - |
723 (15.16) |
4,648 (30.09) |
412 (2.9) |
< 0.001 |
ER/PR + |
4,045 (84.84) |
10,798 (69.91) |
13,818 (97.1) |
||
HER2 |
Negative |
302 (6.33) |
882 (5.71) |
1,113 (7.96) |
< 0.001 |
Positive |
113 (2.73) |
670 (4.34) |
475 (3.34) |
||
Unknown |
4,353 (91.3) |
13,894 (89.95) |
12,622 (88.7) |
||
Grade |
Well Differentiated |
776 (16.28) |
1202 (7.78) |
1519 (10.67) |
< 0.001 |
Moderately Differentiated |
1505 (31.56) |
3866 (25.03) |
4499 (31.62) |
||
Poorly Differentiated |
1395 (29.26) |
7247 (46.92) |
5363 (37.69) |
||
Cell Type Not Determined |
1092 (22.9) |
3131 (20.27) |
2849 (20.02) |
||
Tumor Size (cm) |
Mean |
1.34 |
1.79 |
1.42 |
< 0.001 |
Median |
0.8 |
1.2 |
1 |
||
Std. Dev |
3.48 |
2.89 |
2.32 |
||
Tumor Size (quartile) (cm) |
> = 0.1, < = 0.5 |
1257 (26.36) |
2790 (18.06) |
3097 (21.76) |
< 0.001 |
> 0.5, < = 1 |
820 (17.2) |
2537 (16.42) |
2600 (18.27) |
||
> 1, < = 1.9 |
660 (13.84) |
2724 (17.64) |
2311 (16.24) |
||
> 1.9, < = 9.8 |
650 (13.63) |
3323 (2.51) |
2245 (15.78) |
||
Unknown |
1381 (28.96) |
4072 (26.36) |
397 (27.95) |